FDA targets company making cancer treatment claims (Nutraingredients.com)
7/20/2007 - In another move to prevent dietary supplements infringing on the territory of pharmaceuticals, the US Food & Drug Administration (FDA) has issued a warning to Zeo Health for three of its products.

Taking another look at managing PMAs (Medical Device Link)
Four years ago, IVD Technology magazine published a series of articles on managing premarket approvals (PMA) for IVDs. 1 3 As an update, this article describes how to manage postmarket PMA activities involving additional FDA approvals for product modifications following initial PMAs, and managing postmarket clinical studies if they are required as a condition for granting a PMA.